We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBIT icon
3226
XBiotech
XBIT
$68M
$443K ﹤0.01%
+78,668
New +$529K
VVX icon
3227
V2X
VVX
$2.83B
$442K ﹤0.01%
13,200
-2,600
-16% -$92K
ICD
3228
DELISTED
Independence Contract Drilling, Inc.
ICD
$441K ﹤0.01%
140,800
-210,200
-60% -$815K
SRG
3229
Seritage Growth Properties
SRG
$136M
$440K ﹤0.01%
+84,500
New +$754K
TRAW icon
3230
Traws Pharma
TRAW
$6.85M
$440K ﹤0.01%
13,333
+463
+4% +$15.6K
RSPD icon
3231
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$317M
$439K ﹤0.01%
+12,300
New +$500K
AVDV icon
3232
Avantis International Small Cap Value ETF
AVDV
$19B
$438K ﹤0.01%
+8,300
New +$487K
QQEW icon
3233
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.75B
$437K ﹤0.01%
5,000
+1,600
+47% +$152K
EAR
3234
DELISTED
Eargo, Inc. Common Stock
EAR
$437K ﹤0.01%
29,030
+16,910
+140% +$799K
MTUM icon
3235
iShares MSCI USA Momentum Factor ETF
MTUM
$25.4B
$436K ﹤0.01%
+3,200
New +$470K
CNM icon
3236
Core & Main
CNM
$8.23B
$435K ﹤0.01%
+19,500
New +$452K
RLAY icon
3237
Relay Therapeutics
RLAY
$4.1B
$434K ﹤0.01%
25,900
-1,900
-7% -$40.7K
TALK icon
3238
Talkspace
TALK
$874M
$434K ﹤0.01%
255,200
+120,200
+89% +$181K
CASH icon
3239
Pathward Financial
CASH
$1.86B
$433K ﹤0.01%
+11,200
New +$477K
RRX icon
3240
Regal Rexnord
RRX
$13.7B
$433K ﹤0.01%
+3,815
New +$485K
VONE icon
3241
Vanguard Russell 1000 ETF
VONE
$8.27B
$430K ﹤0.01%
2,500
+900
+56% +$168K
FNDC icon
3242
Schwab Fundamental International Small Company Index ETF
FNDC
$3.05B
$429K ﹤0.01%
14,100
+3,700
+36% +$122K
SMHI icon
3243
SEACOR Marine Holdings
SMHI
$256M
$429K ﹤0.01%
74,500
+45,400
+156% +$359K
VNM icon
3244
VanEck Vietnam ETF
VNM
$491M
$429K ﹤0.01%
+29,800
New +$488K
YPF icon
3245
YPF
YPF
$206B
$429K ﹤0.01%
131,504
-395,770
-75% -$1.71M
DMRA
3246
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.78B
$427K ﹤0.01%
9,868
+821
+9% +$37.7K
ATYR
3247
aTyr Pharma
ATYR
$47.6M
$427K ﹤0.01%
150,825
+39,970
+36% +$145K
TDIV icon
3248
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.18B
$426K ﹤0.01%
8,500
+3,100
+57% +$168K
TRVI icon
3249
Trevi Therapeutics
TRVI
$2.59B
$426K ﹤0.01%
151,500
+35,500
+31% +$87.2K
XSD icon
3250
State Street SPDR S&P Semiconductor ETF
XSD
$2.72B
$425K ﹤0.01%
+2,800
New +$486K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.